M Konrad

490 total citations
8 papers, 346 citations indexed

About

M Konrad is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Immunology. According to data from OpenAlex, M Konrad has authored 8 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Public Health, Environmental and Occupational Health, 6 papers in Hematology and 5 papers in Immunology. Recurrent topics in M Konrad's work include Acute Lymphoblastic Leukemia research (6 papers), Acute Myeloid Leukemia Research (3 papers) and Hematopoietic Stem Cell Transplantation (2 papers). M Konrad is often cited by papers focused on Acute Lymphoblastic Leukemia research (6 papers), Acute Myeloid Leukemia Research (3 papers) and Hematopoietic Stem Cell Transplantation (2 papers). M Konrad collaborates with scholars based in Austria, Germany and United States. M Konrad's co-authors include Louis M. Weiner, Robert L. Comis, Eric S. Groves, Robert J. Bauer, Arthur E. Frankel, Oskar A. Haas, E. Renate Panzer-Grümayer, E. Renate Panzer‐Grümayer, Martin Schrappe and Jacques J. M. van Dongen and has published in prestigious journals such as Blood, Leukemia and Genes Chromosomes and Cancer.

In The Last Decade

M Konrad

8 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Konrad Austria	7	187	141	115	68	66	8	346
Lüder Hinrich Meyer Germany	10	170 0.9×	144 1.0×	44 0.4×	181 2.7×	46 0.7×	24	381
Larry Herrera United States	10	80 0.4×	85 0.6×	125 1.1×	104 1.5×	6 0.1×	13	415
Ameera Alsadeq Germany	7	90 0.5×	63 0.4×	114 1.0×	62 0.9×	31 0.5×	16	264
Lorenz Bastian Germany	7	59 0.3×	73 0.5×	80 0.7×	86 1.3×	12 0.2×	24	209
Adriaansen Hj Netherlands	6	205 1.1×	218 1.5×	88 0.8×	91 1.3×	11 0.2×	7	360
Joaquina Mascarenhas United States	3	50 0.3×	39 0.3×	78 0.7×	237 3.5×	7 0.1×	3	322
Juan Carlos Balandrán Mexico	10	64 0.3×	95 0.7×	89 0.8×	113 1.7×	25 0.4×	19	282
Samuel Gusscott Canada	8	122 0.7×	92 0.7×	45 0.4×	210 3.1×	27 0.4×	16	345
Gabriele Körner Germany	7	222 1.2×	194 1.4×	34 0.3×	68 1.0×	78 1.2×	7	299
Véronique Della-Valle France	7	85 0.5×	162 1.1×	56 0.5×	170 2.5×	14 0.2×	11	362

Countries citing papers authored by M Konrad

Since Specialization

Citations

This map shows the geographic impact of M Konrad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Konrad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Konrad more than expected).

Fields of papers citing papers by M Konrad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Konrad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Konrad. The network helps show where M Konrad may publish in the future.

Co-authorship network of co-authors of M Konrad

This figure shows the co-authorship network connecting the top 25 collaborators of M Konrad. A scholar is included among the top collaborators of M Konrad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Konrad. M Konrad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Fischer, Susanna, Georg Mann, M Konrad, et al.. (2007). Screening for leukemia- and clone-specific markers at birth in children with T-cell precursor ALL suggests a predominantly postnatal origin. Blood. 110(8). 3036–3038. 16 indexed citations

Velden, Vincent H. J. van der, E. Renate Panzer‐Grümayer, Giovanni Cazzaniga, et al.. (2007). Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting. Leukemia. 21(4). 706–713. 91 indexed citations

Hübner, Sílvia de Oliveira, Giovanni Cazzaniga, T Flohr, et al.. (2003). High incidence and unique features of antigen receptor gene rearrangements in TEL–AML1-positive leukemias. Leukemia. 18(1). 84–91. 26 indexed citations

Konrad, M, et al.. (2003). Clonal variation of the immunogenotype in relapsed ETV6/RUNX1‐positive acute lymphoblastic leukemia indicates subclone formation during early stages of leukemia development. Genes Chromosomes and Cancer. 39(2). 156–160. 21 indexed citations

Konrad, M, Markus Metzler, Simon Panzer, et al.. (2003). Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone. Blood. 101(9). 3635–3640. 62 indexed citations

Schneider, M., Klaudia Hettinger, Susanne Matthes‐Martin, et al.. (2001). Influence of transplantation regimen on prognostic significance of high-level minimal residual disease before allogeneic stem cell transplantation in children with ALL. Bone Marrow Transplantation. 28(11). 1087–1089. 2 indexed citations

Weiner, Louis M., Robert L. Comis, Arthur E. Frankel, et al.. (1989). Phase I evaluation of an anti-breast carcinoma monoclonal antibody 260F9-recombinant ricin A chain immunoconjugate.. PubMed. 49(14). 4062–7. 102 indexed citations

Welte, Karl, et al.. (1988). Phase I trial of recombinant interleukin-2 and cyclophosphamide: augmentation of cellular immunity and T-cell mitogenic response with long-term administration of rIL-2.. PubMed. 7(5). 457–72. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact